Humanized antibody against CD18
US5985279A · kind A · utility
30Cited by
11References
28Claims
0Family size
Inventors
Key dates
| Filing date | Mar 23, 1994 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Mar 23, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Humanized antibodies and fragments thereof that bind human CD18 are disclosed. Nucleic acids encoding anti-CD18 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-CD18 antibodies are also encompassed by the invention. Pharmaceutical compositions comprising the antibodies of the invention are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.